Cardioprotective Effect of Polydatin on Ventricular Remodeling after Myocardial Infarction in Coronary Artery Ligation Rats

Abstract

The purpose of this study was to explore the effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats and to elucidate the underlying mechanisms. A rat model of ventricular remodeling after myocardial infarction was established by left coronary artery ligation. Rats with coronary artery ligation were randomly divided into five groups: control, plus 40 mg/kg captopril, plus 25 mg/kg polydatin, plus 50 mg/kg polydatin, and plus 100 mg/kg polydatin. The sham-operated group was used as a negative control. Rats were administered intragastrically with the corresponding drugs or drinking water for seven weeks. At the end of the treatment, the left ventricular weight index and heart weight index were assessed. The cross-sectional size of cardiomyocytes was measured by staining myocardium tissue with hematoxylin and eosin. Collagen content was counted by Sirius red in aqueous saturated picric acid. The concentrations of angiotensin I, angiotensin II, aldosterone, and endothelin 1 in myocardium or serum were determined by radioimmunoassay. Hydroxyproline and nitric oxide concentrations and glutathione peroxidase and catalase activities in serum were measured by ultraviolet spectrophotometry. Our results showed that seven weeks of polydatin treatment resulted in a significantly reduced left ventricular weight index, heart weight index, serum concentrations of hydroxyproline and aldosterone, an increased concentration of nitric oxide as well as enhanced activities of glutathione peroxidase and catalase. Myocardial angiotensin I, angiotensin II, and endothelin 1 levels were also reduced. The cardiomyocyte cross-sectional area and collagen deposition diminished. This study suggests that polydatin may attenuate ventricular remodeling after myocardial infarction in coronary artery ligation rats through restricting the excessive activation of the renin-angiotensin-aldosterone system and inhibiting peroxidation.

Key words

polydatin - myocardial infarction - ventricular remodeling - coronary artery ligation - renin-angiotensin-aldosterone system - peroxidation

• References

• 1 Pani L, Pecorelli S, Rosano G, Anker SD, Peracino A, Fregonese L, Prasad K, Rasi G. Steps forward in regulatory pathways for acute and chronic heart failure. Eur J Heart Fail 2015; 17: 3-8
• 2 Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000; 5: 167-173
• 3 Kai H. Cardiac remodeling in chronic heart failure. Nihon Rinsho 2006; 64: 855-860
• 4 Katz AM, Zile MR. New molecular mechanism in diastolic heart failure. Circulation 2006; 113: 1922-1925
• 5 Cheng Y, Zhang HT, Sun L, Guo S, Ouyang S, Zhang Y, Xu J. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res 2006; 1110: 193-200
• 6 Zhang LP, Wei Y, Song SL, Cheng M, Zhang Y. Effect of polydatin on action potential in ventricular papillary muscle of rat and the underlying ionic mechanism. Acta Physiol Sin 2011; 63: 48-54
• 7 Miao Q, Wang S, Miao S, Wang J, Xie Y, Yang Q. Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito KATP activation. Phytomedicine 2011; 9: 8-12
• 8 Xing WW, Wu JZ, Jia M, Du J, Zhang H, Qin LP. Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Biomed Pharmacother 2009; 63: 457-462
• 9 Huang HX, Zhao Q, Jin CH. Effect of polydatin on lipopolysaccharide induced leucocyte chemotaxis. Di Yi Jun Yi Da Xue Xue Bao 2003; 23: 1253-1256
• 10 Gao JP, Chen CX, Gu WL, Wu Q, Wang Y, Lü J. Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models. Fitoterapia 2010; 81: 953-960
• 11 Zhang LP, Ma HJ, Bu HM, Wang ML, Li Q, Qi Z, Zhang Y. Polydatin attenuates ischemia/reperfusion-induced apoptosis in myocardium of the rat. Sheng Li Xue Bao 2009; 61: 367-372
• 12 Hsieh SR, Tsai DC, Chen JY, Tsai SW, Liou YM. Green tea extract protects rats against myocardial infarction associated with left anterior descending coronary artery ligation. Pflugers Arch 2009; 458: 631-642
• 13 Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 2013; 128: 388-400
• 14 Ding L, Dong L, Chen X, Zhang L, Xu X, Ferro A, Xu B. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation 2009; 120: 764-773
• 15 Shao MJ, Wang SR, Zhao MJ, Lv XL, Xu H, Li L, Gu H, Zhang JL, Li G, Cui XN, Huang L. The Effects of Velvet Antler of Deer on Cardiac Functions of Rats with Heart Failure following Myocardial Infarction. Evid Based Complement Alternat Med 2012; 2012: 825056
• 16 Bai WW, Xing YF, Wang B, Lu XT, Wang YB, Sun YY, Liu XQ, Guo T, Zhao YX. Tongxinluo Improves Cardiac Function and Ameliorates Ventricular Remodeling in Mice Model of Myocardial Infarction through Enhancing Angiogenesis. Evid Based Complement Alternat Med 2013; 2013: 813247
• 17 Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005; 45: 657-687
• 18 Zhang LP, Yang CY, Wang YP, Cui F, Zhang Y. Protective effect of polydatin against ischemia/reperfusion injury in rat heart. Sheng Li Xue Bao 2008; 60: 161-168
• 19 Katz AM. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses. J Cell Mol Med 2003; 7: 1-10
• 20 Albert NM, Lewis C. Recognizing and managing asymptomatic left ventricular dysfunction: after myocardial infarction. Crit Care Nurse 2008; 28: 20-37
• 21 Zornoff LA, Paiva SA, Duarte DR, Spadaro J. Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol 2009; 92: 157-164
• 22 Remme WJ. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy. Cardiovasc Drugs Ther 2003; 17: 349-360
• 23 Adams jr. KF. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure. Am J Health Syst Pharm 2004; 61 (Suppl. 02) S4-S13
• 24 Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24: 983-991
• 25 Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, OʼConnell TD, Simpson PC, Lorell BH. Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 2004; 10: 511-518
• 26 Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321
• 27 Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007; 76: 8-18
• 28 Slătineanu L, Aursulesei V, Petriş A, Datcu G, Datcu MD. Correlation between plasma level of endothelin-1 and heart remodeling in dilated cardiomyopathy. Rev Med Chir Soc Med Nat Iasi 2007; 111: 345-351
• 29 Yazici M, Demircan S, Durna K, Sahin M. The relation between endothelin-1 levels and myocardial injury in chronic ischemic heart failure. Heart Vessels 2005; 20: 95-99
• 30 Lei J, Vodovotz Y, Tzeng E, Billiar TR. Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide 2013; 35: 175-185
• 31 Leichtweis S, Ji LL. Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiol Scand 2001; 172: 1-10
• 32 Crawford A, Fassett RG, Coombes JS, Kunde DA, Ahuja KD, Robertson IK, Ball MJ, Geraghty DP. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrol Dial Transplant 2011; 26: 2806-2813
• 33 Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci 2004; 61: 192-208